Finally, we analyzed the secretion of matrix-metalloproteinase 9 (MMP9), an enzyme contributing to neuroinflammation, found altered in the serum and CSF of RRMS patients [30,31]. This evidence concerns the gene MMP9 and relapsing-remitting multiple sclerosis.